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Material and Methods: An open label, non-comparative, multi-
centric, post marketing observational study was conducted in >18
years of patients with ST elevated myocardial infarction (STEMI)
receiving Retelex. All patients received 20 units Retelex within 6
hours after the onset of acute myocardial infarction (AMI) symp-
toms. The dose was given as two 10 unit Intravenous injections
each over two minutes 30 minutes apart.
Evaluation criteria: Patients were followed on day 1, 3, 5/7 and 30.
The primary evaluation criteria was total number of patients
showing clinically successful thrombolysis based on 50% resolu-
tion of ST-elevation in the maximum affected ( adjacent) leads
within 90e120 minutes of initiation of Reteplase and resolution of
chest pain. Secondary evaluation criteria included LV function by
2D echo after 24 hrs and within 7 days after thrombolysis, per-
centage of patient requiring rescue PCI, percentage of patient
underwent angioplasty or CABG after thrombolysis. Door to nee-
dle time was also recorded in patients receiving the study drug.
Global assessment of efficacy and safety was done by patient as
well as investigator. All adverse events were recorded for safety
assessment.
Results: A total of 228 patients were enrolled out of which 140
were having diabetes mellitus. Out of all patients, 68.9% had ST
elevated anterior wall myocardial infarction. Resolution of 50% of
ST elevation and resolution of chest pain was reported in 90.50%
and 95.4% patients respectively. ). No significant difference was
seen in primary efficacy variables between diabetes versus non-
diabetes patients (p ¼ 0.1538 for 50% ST elevation resolution, p ¼
0.4031 resolution of chest pain). Themean LV function by 2 D echo
after 24 hours and within 7 days after thrombolysis was 46.79
(+9.33). Rescue PCI was required by 7.6 % patients while angio-
plasty and CABGwas done in 22% and 16.8% patients respectively.
No significant difference was seen in diabetes versus non-dia-
betes patients requiring rescue PCI (p ¼ 0.1059), angioplasty (p ¼
0.2172) and CABG (p ¼ 0.9128). The incidence of adverse event in
this study was 5.3%.
Conclusion: Reteplase IV Injection-recombinant plasminogen
activator is effective and well tolerated in the management of ST
elevated myocardial infarction (STEMI) in Indian patients
including diabetes patients.
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Background: The association between overt hypothyroidism and
coronary artery disease has been often observed in many studies.
Less evident is the data on asymptomatic hypothyroidismwithout
clinical manifestations and with mild elevation of thyroid stim-
ulating hormone.
Methods: It is a prospective observational study of about 1200
patients with Ischemic heart disease. 240(20%) patients were
observed to have Hypothyroidism. Consecutive 75 (31.25%) pa-
tients with hypothyroidism and ischemic heart disease was
analyzed for the present study.
Results: Incidence of Hypothyroid patients among 1200 Ischemic
Heart Disease patients who were admitted in our centre during a
period of 18 months from 1st August 2012 after satisfying the
exclusion criteria was 75(6.25%) 31 males & 24 females. Newly
detected cases of hypothyroidism was 22(29.3%)13 males & 9 fe-
males, of which 12 patients was diagnosed as subclinical hypo-
thyroidism and was initiated treatment and self reported cases of
Hypothyroidism was 53(70.6%) 27 males & 26 females.
Out of the 22 newly reported cases of Hypothyroidism 14(63.6%)
patients had elevated levels of total cholesterol(>200 mg/dL),
LDL(>150), HDL(<40 mg/dL, triglycerides(>150mg/dL) for which
statin therapy was initiated and 5 (22.7%) patients was on statin
therapy for dyslipidemia with normal levels of lipid profile and
with average statin dose of 20 mg daily. 3 patients had normal
values of total cholesterol, LDL, HDL, triglycerides.
Site of coronary artery lesion in self reported case of hypothy-
roidism in ischemic heart disease patients was LAD-32.08%, LCX-
26.42%, RCA-15.09%, and others-3.77%. Site of coronary artery
lesion in newly detected case of hypothyroidism in ischemic heart
disease patients was LAD-40.91%, RCA-22.73, LCX-13.64% and
others-4.55%. PTCA was done in 78.7%% of the patient under
study, medical management and follow up initiated in 18.7% and
CABG in 2.6% patients.
Conclusion: The incidence of hypothyroidism among our study
populationwith ischemic heart diseasewas 6.25%. In self reported
cases of reported cases of Hypothyroidism, 43.4% of patients was
on stain therapy for Dyslipidemia and 30.18% patients was diag-
nosed as new cases of Dyslipidemia. In newly reported cases of
hypothyroidism 63.6% patients was diagnosed as new cases of
Dyslipidemia. LAD lesion(44%) was dominating in both self re-
ported and newly detected cases of hypothyroidismwith ischemic
heart disease.
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Background: High levels of mean platelet volume (MPV) may be
associated with adverse outcomes in patients with myocardial
infarction (MI). We examined the association between MPV and
the risk of death and adverse cardiovascular outcomes in patients
with MI.
Methods: We studied consecutive patients with MI admitted to a
tertiary care hospital during a period of 1year. MPV was measured
at admission and at third month. Patients were followed-up for
one-year primary composite outcome of cardiovascular death,
stroke, fatal or nonfatal MI and cardiac failure. Patients were
classified according to tertile of baseline MPV.
Results: A total of 1206 MI patients, including 934 males (77.4%)
and 272 females (22.6%) were studied. The mean age of the study
population was 55.93 ± 11.07 years. At one-year follow-up, 292
(28.57%) primary outcome occurred: cardiovascular mortality 78
(7.6%), fatal or nonfatal MI 153 (15.0%), stroke 30 (2.9%), and car-
diac failure 128 (12.52%). Highest tertile MPV patients had higher
primary outcome as compared with those with MPV in the lowest
tertile (adjusted OR ¼ 1.70; 95% CI: 1.18 to 2.45; p ¼ 0.01). Total
mortality was also more in high MPV group (adjusted OR 2.83; 95%
CI: 1.49 to 5.35; p < 0.001). There were no significant changes in
meanMPV values at admission from those at thirdmonth interval
(9.15 ± 0.99 Vs 9.19 ± 0.94; p ¼ 0.2).
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Conclusions: Elevated MPV is associated with worse outcome in
patients with acute MI. ElevatedMPV in these patientsmay be due
to inherently large platelets.
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Background: Coronary artery calcification leads to reduced
vascular compliance, abnormal vasomotor responses, and
impaired myocardial perfusion. The presence of coronary artery
calcification is associated with worse outcomes in patients un-
dergoing revascularization.
Methods: We prospectively analysed the coronary angiograms
and clinical profiles of all patients who underwent coronary
angiogram which showed fluoroscopically visible calcification.
Various parameters such as age, sex, hypertension, diabetes,
cholesterol levels, smoking, presence of fluoroscopically visible
calcium and severity of coronary artery disease were analysed. A
total of 100 patients were studied.
Results: The average age of the patients was 64 years. 70% of the
patients had diabetes mellitus and 70% of the patients were hy-
pertensive. 30% of the patients had, anterior wall myocardial
infarction, another 30 % of them had inferior wall myocardial
infarction, and another 30% of them presented with unstable
angina. 10% of the patients had NSTEMI. 87% of the patients
studied had dyslipidemia. Angiographically, 65% of the patients
with fluoroscopically visible calcium had double vessel disease
and 28% had triple vessel disease. 7% had no hemodynamically
significant flow limiting lesion. 93% of the patients had fluoro-
scopically visible calcium in the proximal Left anterior
descending artery (LAD). Additionally 20% of the patients had
fluroscopically visible calcium in the proximal RCA and 10 % had
fluroscopically visible calcium in the left main coronary artery
(LMCA).
Conclusion: It is interesting to note that all the patients with
fluoroscopically visible calcium either had double vessel disease
or triple vessel disease and none of them had single vessel dis-
ease. This correlates well with the fact that fluoroscopically visible
calcium is amarker of severe coronary artery disease. To conclude
fluroscopically visible calcium correlates well with angiographic
coronary artery disease severity.
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Background: Association of coronary artery disease & left bundle
branch block is studied extensively. But there are few studies
with right bundle branch block association with coronary artery
disease. Hence, this study is done to know clinical and angio-
graphic correlation of chest pain associated right bundle branch
block.
Aims and objectives: Clinical and angiographic correlation of
chest pain with right bundle branch block.
Materials and Methods: This is prospective study conducted in
our hospital. It is one year study conducted from Jan 2013 still
undergoing. Total 30 patients enrolled till date.
Results: Out of 30 cases 26 were males and 4 were females. Most
patients were in age group 50e70 years. Presentations like atypical
chest pain in 2, 13 patients hadmyocardial infarction, 2 had stable
angina, 12 had unstable angina. In myocardial infarction group 11
had anterior wall myocardial infarction, one had inferior wall
myocardial infarction and another patient had posterior wall
myocardial infarction. At presentation 19 patients presented with
breathlessness 2 patients were tread mill test positive, one had
palpitations. 13 patients had normal CKMB and 17 had raised
CKMB, 11 had normal Trop I and 19 had raised Trop I, 11 patients
had dyslipidaemia, 7 patients had mild LV dysfunction, 7 had
moderate LV dysfunction, one had severe LV dysfunction, 15 had
normal LV function. Coronary angiography revealed one had left
main disease, 15 had LAD lesion,6 had LCX lesion, and 8 had RCA
lesion.
Conclusion: We concluded that ischaemic heart disease patient
with RBBB definitely had significant coronary artery disease and
also atypical chest pain with normal cardiac enzymes also found
to be having significant coronary artery disease.
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Background: Coronary artery disease (CAD) is the leading cause of
morbidity and mortality in the present world. Risk factor assess-
ment, prevention and treatment of CAD is an important aspect of
present day research. CHADS2 and CHA2DS2-VASc scores have
been previously used for assessing prognostic risk of thrombo-
embolism in non valvular atrial fibrillation patients. They include
similar risk factors for the development of coronary artery disease
(CAD) and may provide crucial information regarding the severity
of coronary artery lesions. To increase the likelihood of deter-
mining CAD severity, the CHA2DS2-VASc-HS and CHA2DS2-
VASc-HSF score comprising of hyperlipidemia, smoking and
family history respectively in addition to the components of the
CHA2DS2-VASc score andmale instead of female gender. The aim
was to investigate whether these risk scores can be used to predict
CAD severity.
Methods and Results: A total of 1120 consecutive patients who
underwent coronary angiography were enrolled in the study.
Presence of >50% stenosis in a coronary artery was assessed as
significant CAD. Of the patients, 239 had normal coronary angio-
grams and served as group 1. The remaining 881 patients with
coronary stenosis were further classified into 2 groups according
to CADwith stenosis of <50% or > 50%: 338 patients withmild CAD
as group 2 and 543 patients with severe CAD as group 3. The
CHADS2, CHA2DS2-VASc, CHA2DS2-VASc-HS and CHA2DS2-
VASc-HSF scores were significantly different among the 3 groups.
All the four scores correlated significantly with the number of
diseased and the Gensini score. The CHA2DS2-VASc-HS and
CHA2DS2-VASc-HSF score was found to be the best scoring
scheme to predict CAD severity in the area under the curve
comparison of these scoring systems.
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